béo phì và tác hại
Anna Tzontcheva, MD, PhD Anna Tzontcheva, MD, PhD Chair of Clinical Laboratory and Clinical Chair of Clinical Laboratory and Clinical immunology, immunology, Medical University – Sofia, Bulgaria Medical University – Sofia, Bulgaria Abdominal obesity, diabetes and cardiovascular risk 15 th BCLF Congress, 4-7 September 2007 Antalya, Turkey http://www.biyokimya.org/belge/sunu_bclf/06.09.2007/Tzontcheva.ppt • Obesity, particularly intra- abdominal (visceral) obesity, is a leading cause of cardiovascular disease (CVD), insulin resistance, type 2 diabetes, dyslipidaemia, inflammation and thrombosis. • A useful indicator for visceral fat is waist circumference, which is associated with all-cause mortality. Pro-inflammatory adipokines play a causal role in the development of pathologies associated with insulin resistance, type 2 diabetes and CVD.